Craig Wheelock an Associate Professor of Biochemistry and Head of the Unit of Integrative Metabolomics in the Institute of Environmental Medicine at the Karolinska Institute (KI), Stockholm, Sweden. He serves as Director of the Integrative Molecular Phenotyping Laboratory and the small molecule mass spectrometry core facility (KI-SMMS). He is also a Distinguished Visiting Professor of Metabolomics at Nagoya City University, Japan. Professor Wheelock received his doctorate at the University of California Davis in 2002 and conducted post-doctoral studies at Kyoto University, Japan.
Professor Wheelock was a member of the European Respiratory Society (ERS) Science Events Working Group from 2016-2019 and served on the ERS Advocacy Council as the Director of Scientific Relations with the EU from 2020-2023. He was also a Board Member of the International Metabolomics Society from 2016-2020, a founding Board Member of the Nordic Metabolomics Society from 2017-2021, and currently serves on the Metabolomic Epidemiology Task Group. He has served as co-Chair of the Genome Medicine Sweden Coordinating Group for Complex Diseases since 2022 and on the Swedish Fulbright Commission since 2023. He is also a member of the editorial board of the European Respiratory Journal and the American Journal for Respiratory and Critical Care Medicine.
Professor Wheelock leads a research group focusing on molecular phenotyping of respiratory disease, with a particular interest in investigating the role of lipid mediators. The overarching aim is to identify personalized molecular profiles that can be associated with an individual’s lifestyle, environmental exposure, and susceptibility to asthma. He has published over 230 articles in peer-reviewed journals and several book chapters. When not balancing his time between Sweden and Japan, he enjoys teaching his kids to kayak and paddling SUP with his dog.